DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
O’Meara S, Nanda K, Moss AC.
Antibodies to infliximab and risk of infusion reactions in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Inflamm Bowel Dis 2014;
20: 1-6
We do not assume any responsibility for the contents of the web pages of other providers.